Tom Walley

Publication List Details

Period

2001 - 2008

Number

66

Co-Authors

Do quality incentives change prescribing patterns in primary care? An observational study in Scotland (2008)

MacBride-Stewart, Sean P, Elton, Rob, Walley, Tom

Background. The 2004 General Medical Services (GMS) contract introduced financial incentives for the management of chronic illnesses in 10 clinical areas. The effect of the scheme on prescribing is...

Do quality incentives change prescribing patterns in primary care? An observational study in Scotland (2008)

MacBride-Stewart, Sean P, Elton, Rob, Walley, Tom

Background. The 2004 General Medical Services (GMS) contract introduced financial incentives for the management of chronic illnesses in 10 clinical areas. The effect of the scheme on prescribing is...

Do quality incentives change prescribing patterns in primary care? An observational study in Scotland (2008)

MacBride-Stewart, Sean P, Elton, Rob, Walley, Tom

Background. The 2004 General Medical Services (GMS) contract introduced financial incentives for the management of chronic illnesses in 10 clinical areas. The effect of the scheme on prescribing is...

Introducing new health interventions - there's still a long way to go to get health technology evidence into practice (2006)

Gabbay, John, Walley, Tom

Throughout the world, healthcare innovations have put pressure on limited resources while governments and patients have demanded top quality, yet cost effective, services. This makes it increasingly...

Provider incentives and prescribing behaviour in Europe (2005)

Mossialos, Elias, Walley, Tom, Rudisill, Caroline

European policy makers have increasingly moved from primarily focusing on supply-side regulation of pharmaceutical costs to offering incentives for providers’ prescribing behavior. The nature and...

Drug-eluting stents: an early systematic review to inform policy (2004)

Hill, Ruaraidh A., Dündar, Yenal, Bakhai, Ameet, Dickson, Rumona, Walley, Tom

Aims To provide systematic assessment of the clinical effectiveness of drug-eluting stents (DES) versus non-DES to inform national guidance. Methods and results The review was conducted according to...

Influences on GPs' decision to prescribe new drugs--the importance of who says what (2003)

Prosser, Helen, Almond, Solomon, Walley, Tom

Objectives. The aim of this study was to understand the range of factors that influence GPs’ uptake of new drugs Methods. A total of 107 GPs selected purposively from high, medium and low new drug...

A reliability study of an instrument for measuring general practitioner consultation skills: the LIV-MAAS scale (2003)

Enzer, Ian, Robinson, Jude, Pearson, Maggie, Barton, Stuart, Walley, Tom

Objective. To evaluate the reliability of a new tool, the LIV-MAAS, in assessing consultation competence in UK general practice. Design. These were pilot studies, with small numbers of participants....

New drug uptake: qualitative comparison of high and low prescribing GPs' attitudes and approach (2003)

Prosser, Helen, Walley, Tom

Background. Prescribing varies considerably between GPs, and a minority of GPs account for a large proportion of new drug prescribing. Objective. Our aim was to explore the differences in approach...

Investigating consumer perspectives on evaluating health technologies (2001)

Oliver, Sandy, Milne, Ruairidh, Bradburn, Jane D., Buchanan, Phyll, Kerridge, Lynn, Walley, Tom, ...

In a short pilot study we systematically involved healthcare consumers in identifying research topics, and prioritizing, commissioning and reporting evaluations of health technologies. We analysed...

Involving consumers in a needs-led research programme: a pilot project (2001)

Oliver, Sandy, Milne, Ruairidh, Bradburn, Jane, Buchanan, Phyll, Kerridge, Lynn, Walley, Tom, ...

Objectives To describe the methods used for involving consumers in a needs-led health research programme, and to discuss facilitators, barriers and goals. Design In a short action research pilot...

Why do GPs not implement evidence-based guidelines? A descriptive study (2001)

Cranney, Mike, Warren, Erica, Barton, Stuart, Gardner, Katy, Walley, Tom

Background. There is an acknowledged gap between research findings and their implementation in clinical practice despite the existence of effective educational interventions. Objectives. Our aim was...

Treatment for newly diagnosed hypertension: patterns of prescribing and antihypertensive effectiveness in the UK

Walley, Tom, Duggan, Andy K, Haycox, Alan R, Niziol, Christie J

Improved practice in the management of hypertension depends on an understanding of existing patterns of treatment. To describe the management of newly diagnosed hypertension in British general...

Measuring consultation skills in primary care in England: evaluation and development of content of the MAAS scale.

Robinson, J, Walley, Tom, Pearson, M, Taylor, D, Barton, Stuart

BACKGROUND: Consultation skills are essential for general practice. Tools for measuring consultation skills in everyday practice are not well developed AIM: To examine and develop the content...

Understanding why GPs see pharmaceutical representatives: a qualitative interview study.

Prosser, Helen, Walley, Tom

BACKGROUND: Doctors are aware of the commercial bias in pharmaceutical representative information; nevertheless, such information is known to change doctors' prescribing, and augment irrational...

Treatment for newly diagnosed hypertension: patterns of prescribing and antihypertensive effectiveness in the UK

Walley, Tom, Duggan, Andy K, Haycox, Alan R, Niziol, Christie J

Improved practice in the management of hypertension depends on an understanding of existing patterns of treatment. To describe the management of newly diagnosed hypertension in British general...

Measuring consultation skills in primary care in England: evaluation and development of content of the MAAS scale.

Robinson, J, Walley, Tom, Pearson, M, Taylor, D, Barton, Stuart

BACKGROUND: Consultation skills are essential for general practice. Tools for measuring consultation skills in everyday practice are not well developed AIM: To examine and develop the content...

Understanding why GPs see pharmaceutical representatives: a qualitative interview study.

Prosser, Helen, Walley, Tom

BACKGROUND: Doctors are aware of the commercial bias in pharmaceutical representative information; nevertheless, such information is known to change doctors' prescribing, and augment irrational...

The impact of non-compliance on the cost-effectiveness of pharmaceuticals: a review of the literature

Dyfrig A. Hughes, Adrian Bagust, Alan Haycox, Tom Walley

Non-compliance with drug therapies not only limits their effectiveness, but in some instances, is associated with grave clinical sequelae and substantial economic burden. It is important, therefore,...

Teaching safe and effective prescribing in UK medical schools: a core curriculum for tomorrow's doctors

Maxwell, Simon, Walley, Tom

There is a pressing need for medical graduates to be fully prepared to take on the responsibilities of prescribing and to be able to respond to continual inevitable rapid changes in therapeutics. The...

Retrospective analysis of opioid prescriptions in cancer patients in a northern Italian Region

Chinellato, Alessandro, Terrazzani, Gianni, Debetto, Patrizia, Zambon, Paola, Guzzinati, Stefano, Walley, Tom, ...

We evaluated patterns of use of opioids in palliative care across one region in Italy by cross-referencing a cancer registry with unique patient identifiers, with prescription databases. There were...

Evaluating laboratory diagnostic tests

Walley, Tom

International collaboration to set standards and methods is urgently needed

Economic evaluation in health care decision making: evidence from the UK

Mike Drummond, Jonathan Cooke, Tom Walley

Although economic evaluation in health care has a long-standing tradition in the United Kingdom, very little is known about its impact on decision making, particularly following the introduction of...

Economic evaluation in health care decision making: evidence from the UK

Mike Drummond, Jonathan Cooke, Tom Walley

Although economic evaluation in health care has a long-standing tradition in the United Kingdom, very little is known about its impact on decision making, particularly following the introduction of...

Economic Evaluations During Early (Phase II) Drug Development: A Role for Clinical Trial Simulations?

Dyfrig A. Hughes, Tom Walley

Faced with increasing demands on demonstrating cost effectiveness, pharmaceutical companies are required to conduct pharmacoeconomic evaluations throughout the drug development programme. At present,...

Accounting for Noncompliance in Pharmacoeconomic Evaluations

Dyfrig A. Hughes, Adrian Bagust, Alan Haycox, Tom Walley

Noncompliance with prescribed drug regimens is a widespread phenomenon which results in decreased efficacy and is often associated with increased medical expenditures. Despite this, economic...

Outcomes, Outcomes Research and Disease Management: A View from the UK

Tom Walley

The UK National Health Service (NHS) is in the process of further reforms aimed at restoring a national focus to its activities and also at enhancing the quality of the service it provides. Key...

Prescribing at the Interface Between Primary and Secondary Care in the UK: Towards Joint Formularies?

Martin Duerden, Tom Walley

The current divisions in managing prescribing between primary and secondary care in the UK arise from separate budgetary arrangements. These divisions are neither sensible, organisationally efficient...